483 Zhejiang Raybow Pharmaceutical Apr 2014

483 Zhejiang Raybow Pharmaceutical Apr 2014

$119 - Not in Stock

FDA investigators audited the Zhejiang Raybow Pharmaceutical - Taizhou, China facility and issued inspectional observations (via FDA 483) on 29 Apr 2014.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Apr 2014
  • Location: Taizhou, China
  • FEI: 3005842033

Pre-Order Not Available